Results 201 to 209 of about 54,740 (209)

Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies

Nature Reviews Clinical Oncology, 2014
Aisha Miah, Khin Thway, Mark Linch
exaly  

GROWING INTEREST IN COMPLEMENTARY AND ALTERNATIVE CANCER THERAPIES

Ca-A Cancer Journal for Clinicians, 2004
exaly  

Tumour heterogeneity and resistance to cancer therapies

Nature Reviews Clinical Oncology, 2017
Alice Shaw, Ibiayi Dagogo-Jack, Shaw Alice T   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Bettina Ryll, Vivek Subbiah, Razelle Kurzrock   +2 more
exaly  

Approvals in 2017: gene therapies and site-agnostic indications

Nature Reviews Clinical Oncology, 2018
Gideon Blumenthal, Richard Pazdur, Pazdur Richard   +2 more
exaly  

Chimeric antigen receptor T-cell therapies for lymphoma

Nature Reviews Clinical Oncology, 2017
James Kochenderfer, Jennifer Brudno, Brudno Jennifer N   +2 more
exaly  

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

Ca-A Cancer Journal for Clinicians
Rachel Layman, Debu Tripathy
exaly  

Targeted cancer therapies

Nature Reviews Drug Discovery, 2010
exaly  

Alternative Therapies for Curing Cancer: What Do Patients Want? What Do Patients Need?

Ca-A Cancer Journal for Clinicians, 2001
exaly